KL Acquisition, a blank check company formed by Kennedy Lewis targeting the healthcare industry, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50.
The company is led by CEO and Chairman Doug Logigian, who serves as a Partner and President of opportunistic credit manager Kennedy Lewis Investment Management and previously was a Senior Managing Director at Blackstone. He is joined by CFO and Director Richard Gumer, a Managing Director and Head of Life Sciences at Kennedy Lewis and former co-founder and CEO of Life Sciences Alternative Funding, and COO and Director David Kho, a Managing Partner at Kennedy Lewis and a former VP of Bridge Bank.
KL Acquisition plans to leverage its management team's experience and target the healthcare or healthcare-related industries in the US and other developed countries.
KL Acquisition plans to list on the Nasdaq under the symbol KLAQU. Goldman Sachs acted as a lead manager on the deal.
